THIS SUBSCRIPTION AGREEMENT is made as of the 30th day of September, 1999, by and between
Myriad Genetics, Inc. (the "Company"), a Delaware corporation with primary offices at 320 Wakara Way, Salt
Lake City, Utah 84108, U.S.A., and the purchaser whose name and address is set forth below (the "Purchaser").
1. The Purchaser hereby subscribes for 355,000 shares of Common Stock of the Company, U.S. $.01 par value
per share (the "Shares"), at a purchase price of U.S. $14.05 per Share, for an aggregate purchase price of U.S.
2. The Purchaser represents, acknowledges, warrants and covenants with the Company, as of the date hereof
and the closing of the Purchaser's purchase of the Shares, that (i) the Purchaser is a resident of Switzerland and is
not a "U.S. Person" as defined in Regulation S under the United States Securities Act of 1933, as amended (the
"Act"), and is not acquiring the Shares for the account or benefit of any U.S. Person; (ii) the Shares have not
been registered, and will not be registered, under the Act, and the Purchaser will reoffer and resell the Shares
only in accordance with the provisions of Regulation S under the Act, pursuant to registration under the Act, or
pursuant to an available exemption from registration; (iii) the Purchaser will not engage in hedging transactions
with regard to the Shares unless in accordance with the provisions of Regulation S under the Act or otherwise in
compliance with the Act; and (iv) the Purchaser will give each person to whom it transfers the Shares notice of
any restrictions on transfer of the Shares.
The certificate representing the Shares will bear a legend which reflects the foregoing restrictions, substantially
similar to the following:
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "ACT") AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES
OR TO, OR FOR THE BENEFIT OF, U.S. PERSONS AS PART OF THEIR DISTRIBUTION AT ANY
TIME EXCEPT (